ElectroCore Inc (ECOR):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:ElectroCore Inc (ECOR) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7225
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ElectroCore Inc (ElectroCore) is a bioelectronic medicine healthcare company. The company engaged in developing vagus nerve stimulation non-invasively (nVNS) therapy for neurology and rheumatology. It primarily focused on headache such as episodic cluster headache, migraine, and posttraumatic headache; rheumatoid arthritis; sjogren’s syndrome; exploring acute trauma; chronic central inflammation; and neurodegenerative conditions. ElectroCore’s also involved in treating gastric motility disorders, anxiety, depression, and widespread chronic pain. The company operates in the US. ElectroCore is headquartered in New Jersey, the US.

ElectroCore Inc (ECOR) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ElectroCore Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ElectroCore Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
ElectroCore Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ElectroCore Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
ElectroCore Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
ElectroCore Inc, Medical Equipment, Deal Details 10
Venture Financing 10
ElectroCore Raises Additional USD34.9 Million in Venture Financing 10
ElectroCore Raises USD70 Million in Series B Financing 11
ElectroCore Raises USD36 Million in Venture Financing 12
ElectroCore Raises USD1.5 Million in Venture Financing 13
ElectroCore Raises Additional USD10 Million in Second Tranche of Venture Financing 14
ElectroCore Raises US$0.5 Million In Venture Financing Round 15
Partnerships 16
ElectroCore Enters Into Co-Development Agreement With waveCore 16
Equity Offering 17
Electrocore Completes Underwriters Exercise of Over-Allotment Option of IPO of Shares of Shares for USD89.7 Million 17
ElectroCore Inc – Key Competitors 19
ElectroCore Inc – Key Employees 20
ElectroCore Inc – Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Financial Announcements 22
Aug 13, 2018: electroCore announces second quarter financial results 22
Corporate Communications 23
Jul 10, 2018: electroCore Announces Board Changes 23
Aug 29, 2017: Publicis Health CEO Joins electroCore’s Board of Directors 24
Jun 21, 2017: electroCore Announces Appointment of New Chief Medical Officer 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
ElectroCore Inc, Medical Equipment, Key Facts, 2017 2
ElectroCore Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
ElectroCore Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ElectroCore Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
ElectroCore Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ElectroCore Inc, Deals By Market, 2012 to YTD 2018 8
ElectroCore Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
ElectroCore Raises Additional USD34.9 Million in Venture Financing 10
ElectroCore Raises USD70 Million in Series B Financing 11
ElectroCore Raises USD36 Million in Venture Financing 12
ElectroCore Raises USD1.5 Million in Venture Financing 13
ElectroCore Raises Additional USD10 Million in Second Tranche of Venture Financing 14
ElectroCore Raises US$0.5 Million In Venture Financing Round 15
ElectroCore Enters Into Co-Development Agreement With waveCore 16
Electrocore Completes Underwriters Exercise of Over-Allotment Option of IPO of Shares of Shares for USD89.7 Million 17
ElectroCore Inc, Key Competitors 19
ElectroCore Inc, Key Employees 20

List of Figures
ElectroCore Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
ElectroCore Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
ElectroCore Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
ElectroCore Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
ElectroCore Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ElectroCore Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
ElectroCore Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ElectroCore Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[ElectroCore Inc (ECOR):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • OncoTherapy Science Inc (4564):医療機器:M&Aディール及び事業提携情報
    Summary OncoTherapy Science Inc (OncoTherapy) is a biotechnology company that discovers and develops antibody drugs for treating cancer. The company offers products under antibodies, cancer vaccines and small molecule drugs. It provides contract research services. OncoTherapy conducts research and d …
  • ABX Advanced Biochemical Compounds GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary ABX Advanced Biochemical Compounds GmbH (ABX), a subsidiary of Otsuka Holdings Co Ltd is a provider of biochemical compounds that manufactures, develops, and distributes biochemicals for nuclear medicine. The company provides products such as PET and SPECT precursors and reference standards, …
  • EMCORE Corporation (EMKR)-エネルギー分野:企業M&A・提携分析
    Summary EMCORE Corporation (EMCORE) is a communication network infrastructure equipment company that provides optical components and end-to-end solutions. It designs and manufactures indium phosphide optical chips, components, subsystems, and systems. The company produces its products through linear …
  • Abu Dhabi National Energy Co (TAQA):企業の財務・戦略的SWOT分析
    Abu Dhabi National Energy Co (TAQA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • TAG Oil Ltd (TAO):企業の財務・戦略的SWOT分析
    Summary TAG Oil Ltd (TAG Oil) is an oil and gas exploration company engaged in the production of crude oil and natural gas across Canada. The company owns and operates oil and gas properties in Surat Basin and Taranaki Basin. The Taranaki Basin is located to the North Island of New Zealand. The comp …
  • R1 RCM Inc (RCM):企業の財務・戦略的SWOT分析
    R1 RCM Inc (RCM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Berjaya Corporation Berhad (BJCORP):企業の財務・戦略的SWOT分析
    Berjaya Corporation Berhad (BJCORP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • International Game Technology Plc (IGT):企業の財務・戦略的SWOT分析
    International Game Technology Plc (IGT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Cadila Healthcare Ltd (CADILAHC):企業の財務・戦略的SWOT分析
    Cadila Healthcare Ltd (CADILAHC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Liechtensteinische Landesbank Ag:企業の戦略・SWOT・財務分析
    Liechtensteinische Landesbank Ag - Strategy, SWOT and Corporate Finance Report Summary Liechtensteinische Landesbank Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Abramson Cancer Center-製薬・医療分野:企業M&A・提携分析
    Summary Abramson Cancer Center, formerly Penn Medicine's Cancer Center, a subsidiary of University of Pennsylvania is a healthcare service center that provides clinical trials for the prevention, diagnosis and treatment of cancer. The center provides supportive care services, which include integrati …
  • Mizuho Trust & Banking Co Ltd:戦略・SWOT・企業財務分析
    Mizuho Trust & Banking Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Mizuho Trust & Banking Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Petkim Petrokimya Holding AS (PETKM):企業の財務・戦略的SWOT分析
    Summary Petkim Petrokimya Holding AS (Petkim Petrokimya), a subsidiary of State Oil Company of the Azerbaijan Republic, is a chemical company. Its products portfolio includes propylene, acrylonitrile, ethylene, polyvinyl chloride, aromatics, polypropylene, sodium hydroxide, diethylene glycol, polyme …
  • Spectrum Pharmaceuticals Inc (SPPI)-製薬・医療分野:企業M&A・提携分析
    Summary Spectrum Pharmaceuticals Inc (Spectrum) is a biotechnology company that develops and commercializes a pipeline of late-stage clinical and commercial products with focus on hematology and oncology. The company’s marketed drugs include Fusilev (levoleucovorin); Folotyn (pralatrexate injection) …
  • Methanol Chemicals Co (2001):企業の財務・戦略的SWOT分析
    Methanol Chemicals Co (2001) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Saras SpA (SRS):電力:M&Aディール及び事業提携情報
    Summary Saras SpA (Saras) is crude oil refiner and operates refining, marketing, power generation and wind power businesses. The company’s major refinery is Sarroch refinery, on the Southwestern coast of Sardinia. Saras is also active in the production and sale of electricity, and offers industrial …
  • Conatus Pharmaceuticals Inc (CNAT):製薬・医療:M&Aディール及び事業提携情報
    Summary Conatus Pharmaceuticals Inc (Conatus) is a biotechnology company that develops and commercializes novel medicines for the treatment of liver diseases. The company’s lead pipeline candidate includes emricasan, an orally active pan-caspase protease inhibitor which is designed to reduce the act …
  • XenoPort Inc-製薬・医療分野:企業M&A・提携分析
    Summary XenoPort Inc (XenoPort) is a bio-pharmaceutical company which develops and commercializes internally discovered product candidates for the treatment of neurological disorders. It develops Transported Prodrugs through the modification of chemical structure of existing drugs in the market. The …
  • Jubilant Biosys Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Jubilant Biosys Ltd (Jubilant Biosys), a subsidiary of Jubilant Life Sciences Ltd, is a provider of drug discovery and development solutions. The company offers functional discovery services such as toxicology models, computational chemistry, medicinal chemistry, structural biology, drug met …
  • Suzuki Motor Corporation (7269):企業の財務・戦略的SWOT分析
    Suzuki Motor Corporation (7269) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆